Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bosch

Showing results (961-970 of 1,009) with videos related to

Pageof 101
Sort By:
Nature|July 28, 2012
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyN M Archin, A L Liberty, A D Kashuba, et al.
Plos Pathogens|September 21, 2017
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapyAllison S Thomas, Kimberley L Jones, Rajesh T Gandhi, et al.
The Journal of Infectious Diseases|March 13, 2014
HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostatNancy M Archin, Rosalie Bateson, Manoj K Tripathy, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 24, 2010
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practiceJ Z Atary, M de Visser, R van den Dijk, et al.
ESMO Open|July 29, 2021
Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)P Jiménez-Labaig, V Pacheco-Barcia, A Cebrià, et al.
Plos Pathogens|March 6, 2013
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studiesSusanne Eriksson, Erin H Graf, Viktor Dahl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
JACC. Cardiovascular Imaging|July 20, 2020
Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease: A Large Retrospective RegistryVictor Marcos-Garces, Jose Gavara, Jose V Monmeneu, et al.
Actas Dermo-Sifiliograficas|December 23, 2015
Core Content for Undergraduate Medical Education in Spain: Recommendations of the Instructors' Group of the Spanish Academy of Dermatology and Venereology (AEDV)J M Casanova, R M Pujol, C Ferrándiz, et al.
Open Forum Infectious Diseases|March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral TherapyCynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
Pageof 101

Showing results (961-970 of 1,009) with videos related to

Sort By:
Pageof 101
Nature|July 28, 2012
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyN M Archin, A L Liberty, A D Kashuba, et al.
Plos Pathogens|September 21, 2017
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapyAllison S Thomas, Kimberley L Jones, Rajesh T Gandhi, et al.
The Journal of Infectious Diseases|March 13, 2014
HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostatNancy M Archin, Rosalie Bateson, Manoj K Tripathy, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 24, 2010
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practiceJ Z Atary, M de Visser, R van den Dijk, et al.
ESMO Open|July 29, 2021
Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)P Jiménez-Labaig, V Pacheco-Barcia, A Cebrià, et al.
Plos Pathogens|March 6, 2013
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studiesSusanne Eriksson, Erin H Graf, Viktor Dahl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
JACC. Cardiovascular Imaging|July 20, 2020
Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease: A Large Retrospective RegistryVictor Marcos-Garces, Jose Gavara, Jose V Monmeneu, et al.
Actas Dermo-Sifiliograficas|December 23, 2015
Core Content for Undergraduate Medical Education in Spain: Recommendations of the Instructors' Group of the Spanish Academy of Dermatology and Venereology (AEDV)J M Casanova, R M Pujol, C Ferrándiz, et al.
Open Forum Infectious Diseases|March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral TherapyCynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
Pageof 101